Peter Sergo
Seated with his colleagues at a conference table, Anthony-Samuel LaMantia, Ph.D., founding director of the new George Washington Institute for Neuroscience (GWIN), intuitively used his hands when describing a stage in brain development.
On a Wednesday last April, Valerie Hu, Ph.D., professor of Biochemistry and Molecular Biology at GW’s School of Medicine and Health Sciences (SMHS), eagerly anticipated the release of an autism spectrum disorder (ASD) study that she authored and that appeared in the online science journal PLoS One.